Elderly Infection
17
2
4
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
24%
4 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (17)
CT Scan Compared to CXR and LUS in Pneumonia in the Elderly
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"
Long COVID and Its Associations With Health Outcomes in Older Adults
Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
Antibiotic Dosing in Geriatric Patients At the Emergency Department
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
HIV Resilience Qualitative Study Hong Kong
Population Pharmacokinetics and Dosage Individualization of Antibiotics in Elderly Patients
Immunophenotype of Risk in Older Patients Admitted for Pneumonia
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes
Interest of Eosinopenia to Predict In-hospital Mortality Among Elderly Patients
Outcomes in Hospitalized Older Patients With COVID-19
Fixed-dose Amikacin for Elderly UTI
Erythema Migrans in Elderly
The Impact of Oral Nutritional Supplements on the Nutritional Status of Elderly Patients
Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly